Cargando…

Intestinal microbiota changes in Graves’ disease: a prospective clinical study

Graves’ disease (GD) occurs due to an autoimmune dysfunction of thyroid gland cells, leading to manifestations consistent with hyperthyroidism. Various studies have confirmed the link between autoimmune conditions and changes in the composition of intestinal microbial organisms. However, few studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Hui-xian, An, Wen-cheng, Chen, Fang, An, Bo, Pan, Yue, Jin, Jing, Xia, Xue-pei, Cui, Zhi-jun, Jiang, Lin, Zhou, Shu-jing, Jin, Hong-xin, Ou, Xiao-hong, Huang, Wei, Hong, Tian-pei, Lyu, Zhao-hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475298/ https://www.ncbi.nlm.nih.gov/pubmed/32820337 http://dx.doi.org/10.1042/BSR20191242

Ejemplares similares

The Effect of Inactivated SARS-CoV-2 Vaccines on TRAB in Graves’ Disease
por: Huang, LingHong, et al.
Publicado: (2022)

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis
por: Xiang, Hui, et al.
Publicado: (2022)

Graves’ Disease and Rheumatoid Arthritis: A Bidirectional Mendelian Randomization Study
por: Wu, Dide, et al.
Publicado: (2021)

Distribution characteristics of oral microbiota and its relationship with intestinal microbiota in patients with type 2 diabetes mellitus
por: Guo, Xiao-jing, et al.
Publicado: (2023)

Profiles and diagnostic value of intestinal microbiota in schizophrenia patients with metabolic syndrome
por: Xing, Mengjuan, et al.
Publicado: (2023)

Comprehensive Metabolomics Study in Children With Graves’ Disease
por: Xia, Qin, et al.
Publicado: (2021)

Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus
por: He, Qiongyao, et al.
Publicado: (2022)

Gut microbiota profiling revealed the regulating effects of salidroside on iron metabolism in diabetic mice
por: Shi, Jing, et al.
Publicado: (2022)

Identification of Novel Environmental Substances Relevant to Pediatric Graves’ Disease
por: Xia, Qin, et al.
Publicado: (2021)

Effects of Atractylodes Macrocephala Rhizoma polysaccharide on intestinal microbiota composition in rats with mammary gland hyperplasia
por: Ping, Yang, et al.
Publicado: (2023)

Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism
por: Abbara, Ali, et al.
Publicado: (2020)

Asymmetric Graves’ Orbitopathy
por: Panagiotou, Grigorios, et al.
Publicado: (2020)

Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves’ Ophthalmopathy
por: Wang, Yan, et al.
Publicado: (2022)

Immunological Features of Paranasal Sinus Mucosa in Patients with Graves’ Orbitopathy
por: Lu, Yi, et al.
Publicado: (2021)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
por: Le Moli, Rosario, et al.
Publicado: (2020)

Association of variant on the promoter of cluster of differentiation 74 in graves disease and graves ophthalmopathy
por: Liu, Yu-Huei, et al.
Publicado: (2020)

Therapeutic Potential of Targeting Periostin in the Treatment of Graves’ Orbitopathy
por: Jang, Sun Young, et al.
Publicado: (2022)

Antioxidant Therapy in Graves’ Orbitopathy
por: Lanzolla, Giulia, et al.
Publicado: (2020)

Orbital Signaling in Graves’ Orbitopathy
por: Draman, Mohd Shazli, et al.
Publicado: (2021)

Preoperative preparation for Graves’ disease
por: Xu, Tianfeng, et al.
Publicado: (2023)

METTL3 Is Involved in the Development of Graves’ Disease by Inducing SOCS mRNA m6A Modification
por: Song, Rong-hua, et al.
Publicado: (2021)

Compelling Evidence Linking CD40 Gene With Graves’ Disease in the Chinese Han Population
por: Jiang, He, et al.
Publicado: (2021)

Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients
por: Villagelin, Danilo, et al.
Publicado: (2019)

Predictive Value of Gene Polymorphisms on Recurrence after the Withdrawal of Antithyroid Drugs in Patients with Graves’ Disease
por: Liu, Jia, et al.
Publicado: (2017)

Increased Human Interleukin-32 Expression Is Related to Disease Activity of Graves' Disease
por: Yao, Qiuming, et al.
Publicado: (2019)

Gut microbiota and oleoylethanolamide in the regulation of intestinal homeostasis
por: De Filippo, Carlotta, et al.
Publicado: (2023)

Sphingolipids in the Heart: From Cradle to Grave
por: Kovilakath, Anna, et al.
Publicado: (2020)

Update on the surgical management of Graves’ orbitopathy
por: Baeg, Joonyoung, et al.
Publicado: (2023)

Relationships Between Diurnal Changes of Tongue Coating Microbiota and Intestinal Microbiota
por: Guo, Xiao-jing, et al.
Publicado: (2022)

Decreased Treg Cell and TCR Expansion Are Involved in Long-Lasting Graves’ Disease
por: Chen, Ziyi, et al.
Publicado: (2021)

Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides
por: Covasa, Mihai, et al.
Publicado: (2019)

Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves’ Disease
por: Zheng, Dekai, et al.
Publicado: (2021)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
por: Lanzolla, Giulia, et al.
Publicado: (2021)

Mechanisms That Underly T Cell Immunity in Graves’ Orbitopathy
por: Fang, Sijie, et al.
Publicado: (2021)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
por: Fallahi, Poupak, et al.
Publicado: (2021)

Current insights of applying MRI in Graves’ ophthalmopathy
por: Song, Cheng, et al.
Publicado: (2022)

Antithymocyte Globulin as Second-Line Therapy in Graves Orbitopathy—Preliminary Results From a Prospective Single-Center Study
por: Sarnat-Kucharczyk, Monika, et al.
Publicado: (2022)

Association between transferred embryos and multiple pregnancy/live birth rate in frozen embryo transfer cycles: A retrospective study
por: Wu, Xian, et al.
Publicado: (2023)

Neurotransmitter and Intestinal Interactions: Focus on the Microbiota-Gut-Brain Axis in Irritable Bowel Syndrome
por: Chen, Minjia, et al.
Publicado: (2022)

Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves’ Orbitopathy in Orbital Fibroblasts
por: Lee, Ga Eun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7t61chom8oqk1lvn92mohrgn1q